Back
Speaker illustration

Professor Paolo Calabro

Hospital Sant'anna E San Sebastiano, Caserta (Italy)

Articles

Feasibility and implications of patient assessment in the first 24 hours with the 2022 SCAI shock classification in patients with acute coronary syndromes

Date: 3 May 2023

Journal: European Heart Journal - Acute CardioVascular Care

Access
Like
Thumbnail

Reduction of cerebrovascular and peripheral events with PCSK9 inhibitors: Does it just depend on the lowering of the low-density lipoprotein?

Date: 12 November 2022

Journal: European Heart Journal Supplements

Access
Like
Thumbnail

Cardiac involvement in systemic sclerosis: ‘early diagnosis–early management’ approach

Date: 1 November 2020

Journal: European Journal of Preventive Cardiology

Access
Like
Thumbnail

Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk

Date: 29 August 2020

Journal: European Journal of Preventive Cardiology

Access
Like
Thumbnail

Do we need a redefinition of the cardiovascular risk categories used in the 2019 ESC/EAS guidelines on dyslipidaemias?

Date: 7 February 2020

Journal: European Heart Journal

Access
Like
Thumbnail

Evidence of right coronary from mid-left anterior descending coronary: a rare case of coronary anomalous origin

Date: 10 September 2008

Journal: European Heart Journal

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources